July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including transient ischemic attack and stroke in patients undergoing ventricular tachycardia using radiofrequency catheter ablation (RFA).

July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG) monitors to more accurately detect significant arrhythmias than artificial intelligence (AI) algorithm-dependent mobile cardiac telemetry (MCT). The study showed there was a 209% increase in detection when humans evaluated the monitoring as compared to algorithmic monitoring to flag events.

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambulatory Monitor (CAM) patch was presented at the 2021 Heart Rhythm Society (HRS) Conference. 

July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27 million to settle allegations under the False Claims Act involving its implantable cardioverter defibrillators (ICD) and cardiac resyncronization therapy defibrillators (CRT-D). Between November 2014 and October 2016, the Justice Department said St.

July 28, 2021 - ScImage Inc., a provider of cloud-centric cardiovascular and radiology enterprise imaging and reporting solutions, announced a partnership with Cardiology Consultants PA (CCPA). The Spartanburg, S.C., cardiology group consists of 14 physicians, six nurse practitioners, three office locations and a newly opened office-based lab/ambulatory surgical center (OBL/ASC) servicing upstate South Carolina and western North Carolina.

Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21

July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them from the Heart Rhythm Society (HRS) 2021 meeting. For more information on the meeting, visit https://heartrhythm.com.

July 27, 2021 — AliveCor Inc., which offers FDA-cleared, smart-phone enabled personal electrocardiogram (ECG) technology and services, and Acutus Medical, an electrophysiology (EP) lab arrhythmia mapping company, announced a collaboration to assess the integration of data collection tools across the cardiology continuum of care that could potentially advance the field of arrhythmia treatment and disease management. 

July 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to a laser-assisted inferior vena cava (IVC) filter removal device developed by Philips Healthcare. The proposed device is intended for ablating tissue to remove an IVC filter when previous methods of remove it have failed.

July 27, 2021 -- Cardiovascular diseases account for 32% of global deaths. Myocardial infarction, or heart attacks, play a large part in heart diseases and the necrosis of cardiac tissue after blood supply is decreased or stopped.

In APL Bioengineering, by AIP Publishing, researchers from Pohang University of Science and Technology in South Korea take stock of stem cell-laden 3-D bioprinted cardiac patch technologies and their efficacy as a therapeutic and regenerative approach for ischemic cardiomyopathy in reversing scar formation and promoting myocardial regeneration.[1]

July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now